Related content

Comparison of the Bronchodilating Effect of Salmeterol and Zafirlukast in Combination with That of Their Use as Single Treatments in Asthma and Chronic Obstructive Pulmonary Disease

By  

Respiration, Vol. 68, Iss. 5, 2001-10 ,pp. : 452-459

Karger

Access to resources Recommend Favorite

Comparison of the Protective Effect of Formoterol and of Salmeterol against Exercise-Induced Bronchospasm when Given Immediately before a Cycloergometric Test

By  

Respiration, Vol. 69, Iss. 6, 2002-12 ,pp. : 509-512

Karger

Access to resources Recommend Favorite

Comparison of an Inhaled Corticosteroid (Triamcinolone Acetonide) to a Long–Acting Bronchodilator (Salmeterol), the Combination, and Placebo in Mild–Moderate Adult Asthmatic Patients

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 345-346

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Efficacy Crossover Trial Comparing Formoterol-HFA (pMDI) versus Formoterol-DPI (Aerolizer^TM) and Placebo (pMDI or Aerolizer^TM) in Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 6-12

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Crossover Trial Evaluating the Efficacy and Safety Profiles of Two Dose Levels (12 and 24 μg) of Formoterol-HFA (pMDI) vs. Those of a Dose Level (24 μg) of Formoterol-DPI (Foradil^®/Aerolizer^™) and of Placebo (pMDI or Aerolizer) in Moderate to Severe Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 13-19

Karger

Access to resources Recommend Favorite